|
|
Volume 4, Issue 1, February 1997, in PDF
|
   |
Article 53: An Interview with Judith Hardardt
- President and founder of The Hardardt group discusses building and selling a CRO
Article 54: The Strange Case of Dr. Burzynski
- Investigator has been battling FDA for the past 13 years over his use of an unapproved cancer treatment
- The treatment -- antineoplastons -- has received strong support from Buryznski's patients
- The FDA has been unable to curtail Burzynski's use of antineoplaston therapy on his patients; FDA is now bringing him to trial on charges of mail fraud and violation of interstate shipping laws
Article 55: Reaching Out to Minority Investigators
Article 56: Taking the Measure of CROs
- Investigative sites rate the best and worst CROs to work with
- Sites name Covance as the CRO that, in general works best with investigators
- Survey reveals specific steps CROs can take to curry favor with sites
- The survey also identifies specific, common problems in site-CRO relationships
Price: $59.00
|
|
|
